- The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
Ippei Fukada et al, 2017, PLOS ONE CrossRef - Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer
Yang Yuan et al, 2023, Chinese Medical Journal CrossRef - First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
Mostafa M. Elserafi et al, 2018, Journal of the Egyptian National Cancer Institute CrossRef